SE0300959D0 - Methods for predicting therapeutic response to agents acting on the growth hormone receptor - Google Patents
Methods for predicting therapeutic response to agents acting on the growth hormone receptorInfo
- Publication number
- SE0300959D0 SE0300959D0 SE0300959A SE0300959A SE0300959D0 SE 0300959 D0 SE0300959 D0 SE 0300959D0 SE 0300959 A SE0300959 A SE 0300959A SE 0300959 A SE0300959 A SE 0300959A SE 0300959 D0 SE0300959 D0 SE 0300959D0
- Authority
- SE
- Sweden
- Prior art keywords
- methods
- growth hormone
- hormone receptor
- therapeutic response
- agents acting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43486102P | 2002-12-19 | 2002-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0300959D0 true SE0300959D0 (sv) | 2003-04-02 |
Family
ID=23725994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0300959A SE0300959D0 (sv) | 2002-12-19 | 2003-04-02 | Methods for predicting therapeutic response to agents acting on the growth hormone receptor |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040180358A1 (no) |
EP (1) | EP1572738A1 (no) |
JP (1) | JP2006525785A (no) |
KR (1) | KR20050085855A (no) |
CN (1) | CN1747968A (no) |
AU (1) | AU2003278503A1 (no) |
CA (1) | CA2510045A1 (no) |
HR (1) | HRP20050563A2 (no) |
NO (1) | NO20053490L (no) |
RU (1) | RU2005122665A (no) |
SE (1) | SE0300959D0 (no) |
WO (1) | WO2004056864A1 (no) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070029245A (ko) * | 2004-07-08 | 2007-03-13 | 파마시아 앤드 업존 캄파니 엘엘씨 | 성장 호르몬 수용체에 작용하는 약제에 대한 치료 반응의예측 방법 |
GB0600122D0 (en) * | 2006-01-05 | 2006-02-15 | Univ Cardiff | Mutation in the growth hormone receptor |
WO2008109357A1 (en) * | 2007-03-02 | 2008-09-12 | Mdrna, Inc. | Nucleic acid compounds for inhibiting apob gene expression and uses thereof |
ES2643641T3 (es) * | 2009-06-08 | 2017-11-23 | Amunix Operating Inc. | Polipéptidos de hormona del crecimiento y métodos de producción y uso de los mismos |
CN107385034B (zh) * | 2009-09-03 | 2021-08-17 | 弗·哈夫曼-拉罗切有限公司 | 用于治疗、诊断和监控类风湿性关节炎的方法 |
EP2846822A2 (en) * | 2012-05-11 | 2015-03-18 | Prorec Bio AB | Method for diagnosis and treatment of prolactin associated disorders |
CN103014005A (zh) * | 2012-11-22 | 2013-04-03 | 新疆旺源驼奶实业有限公司 | 双峰驼a-fabp蛋白基因、重组蛋白及其克隆方法 |
CN103014007A (zh) * | 2012-11-22 | 2013-04-03 | 新疆旺源驼奶实业有限公司 | 双峰驼α-乳白蛋白基因、重组蛋白及其克隆方法 |
CN103014008A (zh) * | 2012-11-22 | 2013-04-03 | 新疆旺源驼奶实业有限公司 | 双峰驼ghr蛋白基因、重组蛋白及其克隆方法 |
CN112322657B (zh) * | 2020-11-12 | 2023-04-25 | 浙江新码生物医药有限公司 | 一种人生长激素的体外活性检测方法 |
IL309196A (en) | 2021-06-18 | 2024-02-01 | Peptidream Inc | GHR-binding peptide and composition containing it |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5210017A (en) * | 1990-11-19 | 1993-05-11 | Genentech, Inc. | Ligand-mediated immunofunctional hormone binding protein assay method |
US5824642A (en) * | 1994-04-07 | 1998-10-20 | Genentech, Inc. | Treatment of partial growth hormone insensitivity syndrome |
CA2197408A1 (en) * | 1996-02-13 | 1997-08-14 | Kazuo Chihara | Mutant human growth hormones and their uses |
US6080911A (en) * | 1997-04-15 | 2000-06-27 | Ohio University | Mice models of growth hormone insensitivity |
-
2003
- 2003-04-02 SE SE0300959A patent/SE0300959D0/xx unknown
- 2003-11-06 US US10/703,033 patent/US20040180358A1/en not_active Abandoned
- 2003-11-10 CN CNA2003801097023A patent/CN1747968A/zh active Pending
- 2003-11-10 AU AU2003278503A patent/AU2003278503A1/en not_active Abandoned
- 2003-11-10 CA CA002510045A patent/CA2510045A1/en not_active Abandoned
- 2003-11-10 RU RU2005122665/13A patent/RU2005122665A/ru not_active Application Discontinuation
- 2003-11-10 WO PCT/IB2003/005111 patent/WO2004056864A1/en active Application Filing
- 2003-11-10 KR KR1020057011662A patent/KR20050085855A/ko not_active Application Discontinuation
- 2003-11-10 JP JP2004561735A patent/JP2006525785A/ja active Pending
- 2003-11-10 EP EP03769803A patent/EP1572738A1/en not_active Withdrawn
-
2005
- 2005-06-16 HR HR20050563A patent/HRP20050563A2/hr not_active Application Discontinuation
- 2005-07-18 NO NO20053490A patent/NO20053490L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2003278503A1 (en) | 2004-07-14 |
CA2510045A1 (en) | 2004-07-08 |
EP1572738A1 (en) | 2005-09-14 |
RU2005122665A (ru) | 2006-01-20 |
JP2006525785A (ja) | 2006-11-16 |
KR20050085855A (ko) | 2005-08-29 |
CN1747968A (zh) | 2006-03-15 |
NO20053490D0 (no) | 2005-07-18 |
HRP20050563A2 (en) | 2005-12-31 |
NO20053490L (no) | 2005-09-16 |
WO2004056864A1 (en) | 2004-07-08 |
US20040180358A1 (en) | 2004-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053490L (no) | Methods for prediciting therapeutic response to agents acting on the growth hormone receptor | |
BR0316969A (pt) | Tratamento de mal de huntington com epa | |
IN2015KN00290A (no) | ||
ATE552849T1 (de) | Behandlungsverfahren unter verwendung von ctla-4 antikörpern | |
WO2004000094A8 (en) | Predictive markers in cancer therapy | |
WO2000050639A3 (en) | Gene sequence variations with utility in determining the treatment of disease | |
ATE462710T1 (de) | Mutationen in nod2 sind bei patienten mit morbus crohn mit fibrostenosebildung assoziiert | |
EA200800879A1 (ru) | Агонисты ppar гамма для улучшения когнитивной функции у apoe4 отрицательных пациентов | |
AU2003293141A1 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
WO2003057856A3 (en) | Dominant negative proteins and methods thereof | |
WO2004043232A3 (en) | Methods for identifying risk of melanoma and treatments thereof | |
WO2002098355A3 (en) | Methods and reagents for diagnosis and treatment of insulin resistance and related conditions | |
WO2005014846A3 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
WO2004081043A3 (en) | Baff mutants with at least one amino acid substitution and methods of their production | |
AU2001245319A1 (en) | Methods of treating diseases with activated protein c | |
NO993653L (no) | FremgangsmÕte for diagnose, prognose og behandling av glaukom og relaterte sykdommer | |
AU1955899A (en) | Mammalian edg-7 receptor homologs | |
WO2000058510A3 (en) | Schizophrenia associated genes, proteins and biallelic markers | |
WO2005002414A3 (en) | Prognosis determination in ewing sarcoma patients by means of genetic profiling | |
WO2004048546A3 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
TW200617396A (en) | Method | |
WO2004048548A3 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
DK1569961T3 (da) | Splice variant af det menneskelige hypofysevæksthormon | |
AU2003294950A1 (en) | Methods and kits for the selection of animals having certain mild production capabilities, based on the analysis of a polymorphism in the growth hormone receptor gene | |
Scherer | Annotation and Functional Analysis of Human Chromosome 7 for Disease Research |